aa aa aa aa aa
NURSING PRACTICE 13th EDITION GERALYN FRANDSEN’S
aa aa aa aa aa
aa TESTBANK/COMPLETE GUIDE 2024-2025/ALL CHAPTERS 1-61
aa aa aa aa
,Chapter 1: The Foundation of Pharmacology: Quality and Safety
aa aa aa aa aa aa aa aa
1. A aapatient aadiagnosed aawith aaobsessive–compulsive aadisorder aahas aabeen aaprescribed
aaoralaparoxetine aahydrochloride. aaWhat aa is aathe aaexpected aa effect aa for aathis
aaprescription?
A. Curative aaeffect aaon aasymptoms
B. Systemic aaeffect aaon aasymptoms
C. Local aaeffect aaon aasymptoms
D. Parenteral aaeffect aaon aasymptoms
ACCURATE aaANSWER:-B
REASONING:->>>Pharmaceutical aadrug aathat aaproduce aasystemic aaeffects aaare aataken aainto
aathe aabody, aacirculated aathrough aathe aabloodstream aato aatheir aasites aaof aaaction aain aavarious
aabody aatissues, aaand aaeventually aaeliminated aafrom aathe aabody. aaCurative aaagents aaare aagiven
aato aacure aaa aadisease aaprocess. aaInathis aacase, aaparoxetine aahydrochloride aawill aacontrol aathe
aasymptoms aabut aanot aacure aathe aadisorder.
Pharmaceutical aadrug aawith aalocal aaeffects, aasuch aaas aasunscreen aaand aalocal aaanesthetics, aaact
aa mainly aaat aathe aasite aof aaapplication. aaParoxetine aahydrochloride aais aanot aaadministered
aaparenterally. aaParenteral aaagents aare aaadministered aasubcutaneously, aa intramuscularly, aa or
aaintravenously.
POINTS: 1 REFERENCE: p. aa3, aaIntroduction OBJ: 1
NAT: aaHospital aaclient aaNeeds: aaPhysiological aaIntegrity: aaPharmacological aaand
aaParenteral aaTherapiesaTOP: Chapter: aa1: aaThe aaFoundation aaof aaPharmacology:
aaQuality aaand aaSafety
KEY: a a Integrated aaProcess: aaNursing aaProcess
BLM: a a Cognitive aaLevel: aaUnderstand NOT: a a Multiple aaChoice
2. A aahospital aaclient aahas aabeen aaprescribed aaan aaantibiotic. aaThis aapharmaceutical
aadrug aais aaa aanaturally aaoccurring asubstance aathat aahas aabeen
GRADESBOOST.CO
aachemically modified. What aa
M
aa i aas aa aaanother aaname aafor aathis aa type aaof
aapharmaceutical aadrug?
A. Synthetic aadrug
B. Semisynthetic aadrug
C. Biotechnology aadrug
D. Prototype aadrug
ACCURATE aaANSWER:-B
REASONING:->>>Semisynthetic aapharmaceutical aadrug aa(e.g., aamany aaantibiotics) aaare
aanaturally aaoccurring aa substances aathat aahave aabeen aachemically aamodified. aaSynthetic
aapharmaceutical aadrug aaare aamore aastandardized aain aatheir aachemical aacharacteristics, aamore
aaconsistent aain aatheir aaeffects, aaand aaless aalikely aato aaproduce aaallergic aareactions.
aaBiotechnology aapharmaceutical aadrug aainvolve aamanipulating aaDNAaand aa RNA aaand
aarecombining aagenes aainto aahybrid aamolecules aathat aacan aabe aainserted aainto aaliving
aaorganisms. aaPrototype aa pharmaceutical aadrug aaare aathe aa first aa drug aaof aaa aaparticular aagroup
aato aabe aadeveloped.
POINTS: 1 REFERENCE: p. aa3, aaDrug aaSources OBJ:
1
NAT: aaHospital aaclient aaNeeds: aaPhysiological aaIntegrity: aaPharmacological aaand
aaParenteral aaTherapiesaTOP: Chapter: aa1: aaThe aaFoundation aaof aaPharmacology:
aaQuality aaand aaSafety
KEY: a a Integrated aaProcess: aaNursing aaProcess
BLM: a a Cognitive aaLevel: aaUnderstand NOT: a a Multiple aaChoice
3. Which aaclassification aaapplies aato aamorphine?
A. Central aanervous aasystem aadepressant
,B. Central aanervous aasystem aastimulant
, C. Anti-inflammatory
D. Antihypertensive
ACCURATE aaANSWER:-A
REASONING:->>>Pharmaceutical aadrug aaare aaclassified aaaccording aato aatheir aaeffects aaon
aaparticular aabody aasystems, aatheir aatherapeutic aauses, aaand aatheir aa chemical aacharacteristics.
aaMorphine aais aaclassified aa as aaa aacentral aanervous aa system aadepressant aaand aawill aaproduce
aathis aaeffect aain aathe aahospital aaclient. aaAacentral aanervous aasystem aastimulant aaincreases
aaattention aa and aaraises aamood. aa An aa anti-inflammatoryaagent aadecreases aainflammation aaat aathe
aasite aaof aatissue aaor aajoint aainflammation. aaAn aaantihypertensiveaagent aa reduces aablood
aapressure.
POINTS: 1 REFERENCE: p. aa3, aaDrug
aaClassifications aaand aaPrototypesaOBJ: 1
NAT: aaHospital aaclient aaNeeds: aaPhysiological aaIntegrity: aaPharmacological aaand
aaParenteral aaTherapiesaTOP: Chapter: aa1: aaThe aaFoundation aaof aaPharmacology:
aaQuality aaand aaSafety
KEY: a a Integrated aaProcess: aaNursing aaProcess
BLM: a a Cognitive aaLevel: aaRemember NOT: a a Multiple aaChoice
4. A aahospital aaclient aais aaadministered aaamoxicillin. aaThe aageneric aaname aaof aathis
aapharmaceutical aadrug aabelongs aato aawhichadrug aagroup?
A. Selective aaserotonin aareuptake aainhibitors
B. Diuretics
C. Penicillins
D. ACE aainhibitors
ACCURATE aaANSWER:-C
REASONING:->>>The aageneric aaname aaoften aaindicates aathe aadrug aagroup aa(e.g., aapharmaceutical
aadrug
GRADESBOOST.CO
with aageneric aanames aaending aain aa“cillin” aaare aapenicillins). aaSelective aaserotonin
aareuptakeainhibitors aaare aapharmaceutical aadrugs
that aahave aaantidepressant aaeffects; aaSSRI aais aaa aabroad aaclassification, aanot aaa aageneric aaname.
aaDiureticsaare aapharmaceutical aadrugs aathat aaincrease aaurine aaoutput; aadiuretic aais aaa aabroad
aaclassification, aanot aa a aageneric aaname. aaACE aainhibitor aais aathe aabroad aaclassification aafor aathe
aaangiotensin aareceptor aablockers, aanot aatheageneric aa name.
POINTS: 1 REFERENCE: p. aa3, aaDrug aaNames OBJ: 2
NAT: aaHospital aaclient aaNeeds: aaPhysiological aaIntegrity: aaPharmacological aaand
aaParenteral aaTherapiesaTOP: Chapter: aa1: aaThe aaFoundation aaof aaPharmacology:
aaQuality aaand aaSafety
KEY: a a Integrated aaProcess: aaNursing aaProcess
BLM: a a Cognitive aaLevel: aaUnderstand NOT: a a Multiple aaChoice
5. The aaadministration aaof aadiphenhydramine aais aaregulated aaby aawhich aaU.S. aagovernment aa agency?
A. Public aaHealth aaService
B. Federal aaTrade aaCommission
C. Occupational aaSafety aaand aaHealth aaAdministration
D. Food aaand
aa Drug
Administration
a
ACCURATE aaANSWER:-D